Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdds an explicit recruitment notice 'No longer looking for participants' and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). The revision tag updates from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new revision entry for this page.SummaryDifference0.0%

- Check43 days agoChange DetectedThe site release note now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a new, minor update to the site’s release/version information.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s revision/version marker was updated from v3.5.2 to v3.5.3, reflecting a software release on the site.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision: v3.5.0 has been added. Revision: v3.4.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.